In this context, AR activation stimulates proliferation and progression of HER2-enriched and TNBC subtypes, and combinatorial AR and HER2/mTOR inhibition synergistically reduces proliferation and tumor growth in mice [134]. Here, ERBB2 is linked to neoplasm.